Nasdaq · Financials
Core Scientific, Inc./tx (CORZ)
As-reported financials and recent SEC filings for Core Scientific, Inc./tx, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$319.0M
Net income
$-288.6M
Net margin
-90.5%
Diluted EPS
$-0.88
ROE
30.0%
P/E (TTM)
—
Market cap
$8.65B
Debt / equity
-1.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $319.0M | $510.7M | $502.4M | $640.3M | $544.5M |
| Gross profit | $37.9M | $121.1M | $123.5M | $8.4M | $238.9M |
| Operating income | $-245.6M | $-142.1M | $9.0M | $-2.11B | $131.5M |
| Net income | $-288.6M | $-1.44B | $-246.5M | $-2.15B | $47.3M |
| Diluted EPS | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-24
View on EDGAR →42026-06-17
View on EDGAR →42026-06-10
View on EDGAR →42026-06-03
View on EDGAR →42026-05-28
View on EDGAR →32026-05-28
View on EDGAR →42026-05-28
View on EDGAR →8-K2026-05-26
View on EDGAR →Go deeper on CORZ
Search Core Scientific, Inc./tx’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.